Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Exchange Rate Effect (2016 - 2019)

Plus Therapeutics (PSTV) has disclosed Exchange Rate Effect for 7 consecutive years, with -$4000.0 as the latest value for Q1 2019.

  • On a quarterly basis, Exchange Rate Effect fell 110.26% to -$4000.0 in Q1 2019 year-over-year; TTM through Dec 2019 was -$4000.0, a 125.0% decrease, with the full-year FY2019 number at -$4000.0, down 125.0% from a year prior.
  • Exchange Rate Effect was -$4000.0 for Q1 2019 at Plus Therapeutics, down from $26000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $85000.0 in Q1 2016 to a low of -$58000.0 in Q4 2016.
  • A 5-year average of $7000.0 and a median of $1000.0 in 2016 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: plummeted 3000.0% in 2015, then skyrocketed 466.67% in 2016.
  • Plus Therapeutics' Exchange Rate Effect stood at $14000.0 in 2015, then plummeted by 514.29% to -$58000.0 in 2016, then skyrocketed by 96.55% to -$2000.0 in 2017, then surged by 1400.0% to $26000.0 in 2018, then tumbled by 115.38% to -$4000.0 in 2019.
  • Per Business Quant, the three most recent readings for PSTV's Exchange Rate Effect are -$4000.0 (Q1 2019), $26000.0 (Q4 2018), and -$22000.0 (Q3 2018).